VIRP:EPA
Virbac SA
€356.50
arrow_upward
+0.56%(+2.00) 1D
Nov 16, 5:35:18 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VIRP...
Open
€357.00
High
€358.00
Low
€354.50
Mkt. cap
2.99B
Avg. vol.
5.05K
Volume
3.95K
P/E ratio
19.19
52-wk high
€389.50
52-wk low
€297.00
EPS
€18.58
Shares outstanding
8.39M
No. of employees
6K
Open
€357.00
High
€358.00
Low
€354.50
Mkt. cap
2.99B
Avg. vol.
5.05K
Volume
3.95K
P/E ratio
19.19
52-wk high
€389.50
52-wk low
€297.00
EPS
€18.58
Shares outstanding
8.39M
No. of employees
6K
News stories
From web sources and news partners
Bloomberg.com
·
44 minutes ago
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
marketscreener.com
·
1 hour ago
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
Investing.com
·
1 hour ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
21 minutes ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the world’s 6th largest veterinarian pharmaceutical group with a turnover of 1,465 million euros in 2025. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
About Virbac SA
CEO-
Employees6.44K
Founded1968
HeadquartersCarros, Provence-Alpes-CĂ´te d'Azur, France
SectorHealth Care
IndustryPharmaceutical industry
Websitecorporate.virbac.com